IFNA1 and myeloid sarcoma: However, a recent study demonstrated induction of IP-10/CXCL10 mRNA in PBMC derived from MS patients treated with IFN-â in addition to other pro-inflammatory molecules, concluding a more complex mechanism exists [27].